Skip to content
Tirzepatide Report
Provider review

Invigor Medical Tirzepatide Review: Program Prices & Cancellation Terms (2026)

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Confirm the medication and full agreement behind the generic GLP-1/GIP starting quote.

Standout details

  • Public program states the starting figure and consultation/supplies inclusion
  • Refund page identifies practitioner-queue and subscription cancellation cutoffs

Things to consider

  • Generic GLP-1/GIP heading does not establish a named tirzepatide quote or prescribed quantity
  • Starting monthly label does not establish collection schedule, minimum term or future refill price

Invigor’s public treatment page, on Try Invigor, advertises “GLP-1 + GIP Treatments” starting at $350 per month, with a doctor consultation and supplies included. The displayed heading and price card do not explicitly name tirzepatide or specify the dose, quantity or supply period. A current tirzepatide-specific prescription quote therefore needs confirmation; the starting figure is not a verified price for every formulation or future refill.3

What the starting quote establishes

The program describes online prescribing and delivery, but its generic treatment label is not a substitute for the ingredient and formulation on a prescription. Ask which medication is being offered, who will prescribe and dispense it, how much is supplied, and what the complete charge covers. Do not assume the $350 label establishes a standalone monthly purchase without a minimum term or other conditions.3

Program quote

Published detailImportant limit
Starting price$350 per month; not a confirmed quote for every prescription.
Advertised inclusionsDoctor consultation and supplies.
Medication identityHeading/card does not explicitly name tirzepatide.
Personal payment agreementConfirm dose, quantity, supply period, total and renewal.
The public program heading uses a generic GLP-1/GIP label; confirm the ingredient, quantity and agreement before comparing costs.3

The consultation-and-supplies statement helps identify advertised components, but it does not establish every patient’s final invoice. Confirm any additional charges, the amount collected initially, the billing interval and the price after a change in dose or supply. A starting-price comparison is useful only when those details match the alternatives being considered.

Cancellation can close before shipment

Try Invigor’s refund page says new orders must be canceled before the prescription is sent to the practitioner’s queue. It says an order already in that queue cannot be refunded. That cutoff is not described as shipment or pharmacy dispatch, so an order that has not shipped should not be assumed refundable.4

For subscriptions, the page requires cancellation seven days before the renewal date. It also asks patients with order issues to contact the service within 48 hours to submit a claim. Reporting an issue within that window does not itself promise a refund, replacement or approval of a claim.4

Cancellation cutoffs

SituationPublished condition
New-order cancellationBefore prescription enters practitioner queue.
Order already in queuePage says no refund.
Subscription cancellationSeven days before renewal.
Order problemContact within 48 hours to submit a claim; outcome not guaranteed.
The published refund page uses the practitioner queue as the new-order cutoff, not shipment.4

The refund page retains a March 27, 2023 revision label and identifies Ikon Health LLC, doing business as Try Invigor. Ask whether these published terms govern the specific order and how to obtain cancellation confirmation. A policy page’s business name is not independent verification of current ownership or a clinical or pharmacy license.4

The Valhalla Vitality review distinguishes ending a subscription from refunding clinical services or a dispensed prescription. Compare when cancellation takes effect, which order stage ends refund eligibility and how a documented fulfillment problem is handled. Those are separate questions from the advertised treatment price.5

Confirm the medication before comparing evidence

If the prescribed option is compounded tirzepatide, it is not an FDA-approved Zepbound finished product. Our guide to compounded tirzepatide’s legal status explains the distinction. The prescriber should discuss suitability and relevant risks, including Zepbound side effects, gallbladder risk and the thyroid warning.

SURMOUNT-1 and SURMOUNT-5 evaluated specific tirzepatide products and protocols. They do not identify the ingredient in a generic GLP-1/GIP listing or establish outcomes for Invigor’s service.1,2 Read our tirzepatide evidence guide for context.

Verdict

The useful published details are the $350 starting label, consultation and supplies, and explicit cancellation cutoffs. Confirm the actual medication and complete agreement before treating that label as a comparable tirzepatide price. See our Blue Sky MD review and tirzepatide provider comparison for other options.

Frequently asked questions

Does Invigor’s $350 price confirm a specific tirzepatide prescription?

No. Its public card says GLP-1 + GIP Treatments starting at $350 per month. Confirm the ingredient, formulation, prescribed quantity, supply period and complete total.

Can I cancel an Invigor order any time before it ships?

The published policy uses an earlier cutoff: new orders must be canceled before the prescription enters the practitioner’s queue. Once in that queue, the page says no refund.

What are the subscription and order-issue deadlines?

The refund page says subscriptions must be canceled seven days before renewal and order issues reported within 48 hours. Submitting a claim does not guarantee a refund.

References(5)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Invigor Medical (2026). GLP-1 + GIP Treatments. Try Invigor. Read source
  4. Try Invigor (2023). Refund Policy. Try Invigor. Read source
  5. Valhalla Vitality (2026). Terms and Conditions. Valhalla Vitality.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.